The role of non-resolving inflammation in atherosclerosis

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482 · see citing works

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880 · see citing works

Cytokine-mediated regulation of CXCR4 expression in human neutrophils

Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713 · see citing works

The M1 and M2 paradigm of macrophage activation: Time for reassessment

Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · see citing works

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial

(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812 · see citing works

Alternative Activation of Macrophages: An Immunologic Functional Perspective

Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · see citing works

Macrophages in the Pathogenesis of Atherosclerosis

Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · see citing works

Mechanisms of plaque formation and rupture

Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391 · see citing works

The immune system in atherosclerosis

Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,331 · see citing works

Untitled work

(1999) · PubMed · Cited by 2,062 · see citing works

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelká, K., van Vollenhoven, R., Sharp, J. T., Perez, J. L., & Spencer-Green, G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,786 · see citing works

Resolvins

Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · see citing works

Lipid mediator class switching during acute inflammation: signals in resolution

Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · see citing works

Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · see citing works

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,188 · see citing works

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

Clair, E. W. S., van der Heijde, D. M. F. M., Smolen, J. S., Maini, R. N., Bathon, J. M., Emery, P., Keystone, E. C., Schiff, M. H., Kalden, J. R., Wang, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20568 · Cited by 1,143 · see citing works

Macrophage death and defective inflammation resolution in atherosclerosis

Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120 · see citing works

Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways

Serhan, C. N. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997 · see citing works

n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia

The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929 · see citing works

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 926 · see citing works

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915 · see citing works

Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions

Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · see citing works

Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease

Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875 · see citing works

A circadian clock in macrophages controls inflammatory immune responses

Keller, M., Mazuch, J., Abraham, U., Eom, G. D., Herzog, E. D., Volk, H.-D., Kramer, A., & Maier, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906361106 · Cited by 843 · see citing works

Inflammation and plaque vulnerability

Hansson, G. K., Libby, P., & Tabas, I. A. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 809 · see citing works

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C. J., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 767 · see citing works

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 738 · see citing works

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 703 · see citing works

Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins

Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699 · see citing works

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · see citing works

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 667 · see citing works

Infection regulates pro-resolving mediators that lower antibiotic requirements

Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664 · see citing works

Circadian Gene Bmal1 Regulates Diurnal Oscillations of Ly6C hi Inflammatory Monocytes

Nguyen, K. D., Fentress, S. J., Qiu, Y., Yun, K., Cox, J. S., & Chawla, A. (2013) · Science · doi:10.1126/science.1240636 · Cited by 647 · see citing works

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638 · see citing works

Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation

Arita, M., Ohira, T., Sun, Y., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 636 · see citing works

Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis

Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 614 · see citing works

The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution

Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583 · see citing works

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 556 · see citing works

Resolvin D1 and Its Aspirin-triggered 17R Epimer

Sun, Y., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K. H., Campbell, E. L., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 541 · see citing works

Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4 + CD25 + regulatory T cells is interleukin 10 dependent

Kearley, J., Barker, J. E., Robinson, D. S., & Lloyd, C. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051166 · Cited by 517 · see citing works

n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510 · see citing works

Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis

Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509 · see citing works

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

Spite, M., Clària, J., & Serhan, C. N. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.006 · Cited by 464 · see citing works

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 457 · see citing works

Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice

Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422 · see citing works

Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation

Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421 · see citing works

Molecular action of methotrexate in inflammatory diseases.

Chan, E. S. L., & Cronstein, B. N. (2002) · Arthritis Research · doi:10.1186/ar419 · Cited by 419 · see citing works

Pathologic assessment of the vulnerable human coronary plaque

Kolodgie, F. D., Virmani, R., Burke, A. P., Farb, A., Weber, D. K., Kutys, R., Finn, A. V., & Gold, H. K. (2004) · Heart · doi:10.1136/hrt.2004.041798 · Cited by 415 · see citing works

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · see citing works

Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412 · see citing works

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411 · see citing works

The response‐to‐retention hypothesis of atherogenesis reinforced

Williams, K. J., & Tabas, I. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00012 · Cited by 395 · see citing works

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.

Woods, J. W., Evans, J. F., Ethier, D., Scott, S., Vickers, P. J., Hearn, L., Heibein, J. A., Charleson, S. E., & Singer, I. I. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.1935 · Cited by 392 · see citing works

Identification of resolvin D2 receptor mediating resolution of infections and organ protection

Chiang, N., Dalli, J., Colas, R. A., & Serhan, C. N. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150225 · Cited by 388 · see citing works

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · see citing works

Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice

Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D. S., Chiasson, R., Kuriakose, G., Perretti, M., Farokhzad, O. C., & Tabas, I. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1065 · Cited by 360 · see citing works

Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of <i>Apoe</i> ^−/− Mice

Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G., & Tabas, I. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.167197 · Cited by 357 · see citing works

A Novel Ligand of the Formyl Peptide Receptor

Walther, A., Riehemann, K., & Gerke, V. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80323-8 · Cited by 318 · see citing works

Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation

Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 298 · see citing works

Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)

Thorp, E., Vaisar, T., Subramanian, M., Mautner, L., Blobel, C., & Tabas, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263020 · Cited by 298 · see citing works

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.

Maddox, J. F., & Serhan, C. N. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.137 · Cited by 295 · see citing works

Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation

Oh, S. F., Pillai, P. S., Recchiuti, A., Yang, R., & Serhan, C. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42545 · Cited by 292 · see citing works

Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation

El Kebir, D., Gjorstrup, P., & Filep, J. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206641109 · Cited by 289 · see citing works

Lipoxins, Aspirin-Triggered Epi-Lipoxins, Lipoxin Stable Analogues, and the Resolution of Inflammation: Stimulation of Macrophage Phagocytosis of Apoptotic Neutrophils In Vivo

Mitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287 · see citing works

The novel 13 <i>S</i> ,14 <i>S</i> ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A ₄ hydrolase (LTA ₄ H), and shifts macrophage phenotype

Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-227728 · Cited by 283 · see citing works

Annexin-1 and Peptide Derivatives Are Released by Apoptotic Cells and Stimulate Phagocytosis of Apoptotic Neutrophils by Macrophages

Scannell, M., Flanagan, M. B., deStefani, A., Wynne, K. J., Cagney, G., Godson, C., & MADERNA, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4595 · Cited by 282 · see citing works

Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis

Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T. E., & Serhan, C. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044131 · Cited by 278 · see citing works

Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors

Serhan, C. N., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 278 · see citing works

Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor

Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 269 · see citing works

Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 262 · see citing works

MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis

Cai, B., Thorp, E. B., Doran, A. C., Sansbury, B. E., Daemen, M. J. A. P., Dorweiler, B., Spite, M., Fredman, G., & Tabas, I. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90520 · Cited by 262 · see citing works

Living and dying for inflammation: neutrophils, eosinophils, basophils

Geering, B., Stoeckle, C., Conus, S., & Simon, H. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.002 · Cited by 257 · see citing works

MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation

Cai, B., Thorp, E. B., Doran, A. C., Subramanian, M., Sansbury, B. E., Lin, C., Spite, M. R., Fredman, G., & Tabas, I. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524292113 · Cited by 253 · see citing works

Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci

Norling, L. V., Dalli, J., Flower, R. J., Serhan, C. N., & Perretti, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249508 · Cited by 252 · see citing works

Expression of 5-lipoxygenase and leukotriene A 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

Qiu, H., Gabrielsen, A., Agardh, H. E., Wan, M., Wetterholm, A., Wong, C., Hedin, U., Swedenborg, J., Hansson, G. K., Samuelsson, B. O., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602414103 · Cited by 249 · see citing works

Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice

Aiello, R. J., Bourassa, P.-A. K., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247 · see citing works

Airway Lipoxin A4 Generation and Lipoxin A4 Receptor Expression Are Decreased in Severe Asthma

Planagumà, A., Kazani, S. D., Marigowda, G., Haworth, O., Mariani, T. J., Israel, E., Bleecker, E. R., Curran‐Everett, D., ERZURUM, S. C., Calhoun, W. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-061oc · Cited by 247 · see citing works

Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents

Dalli, J., Winkler, J. W., Colas, R. A., Arnardottir, H. H., Cheng, C.-Y. C., Chiang, N., Petasis, N. A., & Serhan, C. N. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.010 · Cited by 246 · see citing works

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement

Hayhoe, R. P. G., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D., & Perretti, M. (2005) · Blood · doi:10.1182/blood-2005-08-3099 · Cited by 239 · see citing works

Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma

Ball, R. Y., Stowers, E. C., Burton, J. H., Cary, N. R. B., Skepper, J. N., & Mitchinson, M. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05463-s · Cited by 236 · see citing works

Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.

Shen, J., Herderick, E. E., Cornhill, J. F., Zsigmond, E., Kim, H. S., Kühn, H., Guevara, J., & Chan, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119029 · Cited by 233 · see citing works

Mechanisms and consequences of efferocytosis in advanced atherosclerosis

Thorp, E., & Tabas, I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209115 · Cited by 231 · see citing works

The molecular mechanisms of the thrombotic complications of atherosclerosis

Libby, P. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01965.x · Cited by 230 · see citing works

Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice

Viola, J. R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309492 · Cited by 226 · see citing works

Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis

Linton, M. F., Babaev, V. R., Huang, J., Linton, E. F., Tao, H., & Yancey, P. G. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0924 · Cited by 225 · see citing works

Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis

Kamaly, N., Fredman, G., Fojas, J. J. R., Subramanian, M., Choi, W. I., Zepeda, K., Vilos, C., Yu, M., Gadde, S., Wu, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b01114 · Cited by 220 · see citing works

Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC–MS/MS

Giera, M. A., Ioan‐Facsinay, A., Toes, R. E. M., Gao, F., Dalli, J., Deelder, A. M., Serhan, C. N., & Mayboroda, O. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.011 · Cited by 210 · see citing works

Role of Leukotriene B4Receptors in the Development of Atherosclerosis: Potential Mechanisms

Subbarao, K., Jala, V. R., Mathis, S., Suttles, J., Zacharias, W., Ahamed, J., Ali, H., Tseng, M. T., & Haribabu, B. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000110503.16605.15 · Cited by 209 · see citing works

Macrophage Phenotypes and Their Modulation in Atherosclerosis

Paoli, F. D., Staels, B., & Chinetti, G. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0621 · Cited by 207 · see citing works

Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement

Watson, R. W. G., Rotstein, O. D., Nathens, A. B., Parodo, J. C., & Marshall, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.945 · Cited by 206 · see citing works

Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis

Hachicha, M., Pouliot, M., Petasis, N. A., & Serhan, C. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1923 · Cited by 200 · see citing works

Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis

Hasturk, H., Abdallah, R., Kantarci, A., Nguyen, D., Giordano, N., Hamilton, J., & Van Dyke, T. E. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305324 · Cited by 199 · see citing works

Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B 4 synthesis by inhibiting a calcium-activated kinase pathway

Fredman, G., Özcan, L., Spolitu, S., Hellmann, J. L., Spite, M. R., Backs, J., & Tabas, I. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410851111 · Cited by 193 · see citing works

Resolvin E2 Formation and Impact in Inflammation Resolution

Oh, S. F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103652 · Cited by 190 · see citing works

Defective Mer Receptor Tyrosine Kinase Signaling in Bone Marrow Cells Promotes Apoptotic Cell Accumulation and Accelerates Atherosclerosis

Ait-Oufella, H., Pouresmail, V., Simon, T., Blanc-Brude, O., Kinugawa, K., Merval, R., Offenstadt, G., Lesèche, G., Cohen, P. L., Tedgui, A., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169078 · Cited by 187 · see citing works

Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice

White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010) · Diabetes · doi:10.2337/db10-0054 · Cited by 185 · see citing works

Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis

Otto, M. C. D. O., Wu, J. H. Y., Baylín, A., Vaidya, D. M., Rich, S. S., Tsai, M. Y., Jacobs, D. R., & Mozaffarian, D. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000506 · Cited by 178 · see citing works

Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells

Ariel, A., Chiang, N., Arita, M., Petasis, N. A., & Serhan, C. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6266 · Cited by 175 · see citing works

From Asthma to Atherosclerosis — 5-Lipoxygenase, Leukotrienes, and Inflammation

Caterina, R. D., & Zampolli, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038190 · Cited by 173 · see citing works

Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet

Li, S., Sun, Y., Liang, C., Thorp, E. B., Han, S., Jehle, A. W., Saraswathi, V., Pridgen, B. C., Kanter, J. E., Li, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199570 · Cited by 167 · see citing works

Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?

Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13818 · Cited by 164 · see citing works

Aspirin-Triggered Lipoxin A4 Stimulates Alternative Activation of Microglia and Reduces Alzheimer Disease–Like Pathology in Mice

Medeiros, R., Kitazawa, M., Passos, G. F., Baglietto-Vargas, D., Cheng, D., Cribbs, D. H., & LaFerla, F. M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.051 · Cited by 163 · see citing works

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

Tardif, J., L’Allier, P. L., Ibrahim, R., Grégoire, J. C., Nozza, A., Cossette, M., Kouz, S., Lavoie, M.-A., Paquin, J., Brotz, T. M., et al. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.937169 · Cited by 157 · see citing works

Impaired Cholesterol Metabolism and Enhanced Atherosclerosis in Clock Mutant Mice

Pan, X., Jiang, X., & Hussain, M. M. (2013) · Circulation · doi:10.1161/circulationaha.113.002885 · Cited by 154 · see citing works

Annexin A1 Counteracts Chemokine-Induced Arterial Myeloid Cell Recruitment

Drechsler, M., de Jong, R., Rossaint, J., Viola, J. R., Leoni, G., Wang, J. M., Grommes, J., Hinkel, R., Kupatt, C., Weber, C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.305825 · Cited by 150 · see citing works

Role of IL-10 in Resolution of Inflammation and Functional Recovery after Peripheral Nerve Injury

Mietto, B. S., Kroner, A., Girolami, E. I., Santos-Nogueira, E., Zhang, J., & David, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2119-15.2015 · Cited by 148 · see citing works

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages

Laguna-Fernandez, A., Checa, A., Carracedo, M., Artiach, G., Petri, M. H., Baumgartner, R., Forteza, M. J., Jiang, X., Andonova, T., Walker, M. E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032801 · Cited by 141 · see citing works

Aspirin-Triggered Lipoxins Override the Apoptosis-Delaying Action of Serum Amyloid A in Human Neutrophils: A Novel Mechanism for Resolution of Inflammation

Kebir, D. E., József, L., Khreiss, T., Pan, W., Petasis, N. A., Serhan, C. N., & Filep, J. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.616 · Cited by 136 · see citing works

Annexin A1 regulates intestinal mucosal injury, inflammation, and repair

Babbin, B. A., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E., Severson, E. A., Flower, R. J., Perretti, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5035 · Cited by 134 · see citing works

Leukotriene Signaling in Atherosclerosis and Ischemia

Bäck, M. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6140-9 · Cited by 134 · see citing works

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability

Petri, M. H., Laguna-Fernández, A., Gonzalez-Diez, M., Paulsson-Berne, G., Hansson, G. K., & Bäck, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvu224 · Cited by 125 · see citing works

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)

Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125 · see citing works

Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro

Chatterjee, B. E., Yona, S., Rosignoli, G., Young, R. E., Nourshargh, S., Flower, R. J., & Perretti, M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405206 · Cited by 121 · see citing works

Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E^−/− mice

Petri, M. H., Laguna‐Fernandez, A., Arnardottir, H., Wheelock, C. E., Perretti, M., Hansson, G. K., & Bäck, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13707 · Cited by 120 · see citing works

CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis

Doran, A. C., Özcan, L., Cai, B., Zheng, Z., Fredman, G., Rymond, C. C., Dorweiler, B., Sluimer, J. C., Hsieh, J., Kuriakose, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94735 · Cited by 113 · see citing works

Resolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets

Fredman, G., Dyke, T. E. V., & Serhan, C. N. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209908 · Cited by 108 · see citing works

Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin

Salic, K., Morrison, M. C., Verschuren, L., Wielinga, P. Y., Wu, L., Kleemann, R., Gjorstrup, P., & Kooistra, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.001 · Cited by 105 · see citing works

The obesity epidemic and its cardiovascular consequences

Behn, A., & Ur, E. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231406.84554.96 · Cited by 104 · see citing works

Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability

Fallahi‐Sichani, M., Flynn, J. L., Linderman, J. J., & Kirschner, D. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103298 · Cited by 99 · see citing works

Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-κB pathway

Yang, L., Chu, Y., Wang, L., Wang, Y., Zhao, X., He, W., Zhang, P., Yang, X., Liu, X., Tian, L., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.001 · Cited by 81 · see citing works

Effect of interleukin 1β inhibition in cardiovascular disease

Qamar, A., & Rader, D. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328359b0a6 · Cited by 81 · see citing works

The anti‐inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells

Zouki, C., Ouellet, S., & Filep, J. G. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.572 · Cited by 79 · see citing works

Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?

Garbin, U., Baggio, E., Stranieri, C., Pasini, A., Manfro, S., Mozzini, C., Vallerio, P., Lipari, G., Merigo, F., Guidi, G. C., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs301 · Cited by 72 · see citing works

Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis

Wong, A., Cook, M. N., Foley, J. J., Sarau, H. M., Marshall, P., & Hwang, S. M. (1991) · Biochemistry · doi:10.1021/bi00102a030 · Cited by 72 · see citing works

Activation of autophagy in macrophages by pro-resolving lipid mediators

Prieto, P., Rosales-Mendoza, C. E., TerrÓn, V., Toledano, V., Cuadrado, A., LÓpez-Collazo, E., Bannenberg, G., Martín-Sanz, P., FernÁndez-Velasco, M., & BoscÁ, L. (2015) · Autophagy · doi:10.1080/15548627.2015.1078958 · Cited by 71 · see citing works

Impaired Production and Diurnal Regulation of Vascular RvD n-3 DPA Increase Systemic Inflammation and Cardiovascular Disease

Colas, R. A., Souza, P. R., Walker, M. E., Burton, M., Zasłona, Z., Curtis, A. M., Marques, R. M., & Dalli, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.312472 · Cited by 71 · see citing works

A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome

Gaztañaga, J., Farkouh, M. E., Rudd, J. H. F., Brotz, T. M., Rosenbaum, D. H., Mani, V., Kerwin, T. C., Taub, R. A., Tardif, J., Tawakol, A. A., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.027 · Cited by 66 · see citing works

A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease

Assimes, T. L., Knowles, J. W., Priest, J. R., Basu, A., Borchert, A., Volcik, K. A., Grove, M. L., Tabor, H. K., Southwick, A. M., Tabibiazar, R., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.003 · Cited by 49 · see citing works

Nutrigenetic Disruption of Inflammation-Resolution Homeostasis and Atherogenesis

Merched, A. J., Serhan, C. N., & Chan, L. (2011) · Lifestyle Genomics · doi:10.1159/000326890 · Cited by 40 · see citing works

The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective

Wittwer, J., Bayer, M., Mosandl, A., Muntwyler, J., & Hersberger, M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.103 · Cited by 39 · see citing works

History and future of omega-3 fatty acids in cardiovascular disease

Sperling, L. S., & Nelson, J. R. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1120190 · Cited by 34 · see citing works

MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis

Ouyang, N., Zhu, C., Zhou, D., Nie, T., Go, M. F., Richards, R. J., & Rigas, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041585 · Cited by 33 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Efferocytosis in health and disease

Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066 · see citing works

The CD47-SIRPα Immune Checkpoint

Logtenberg, M. E. W., Scheeren, F. A., & Schumacher, T. N. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.011 · Cited by 750 · see citing works

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

Chen, W., Schilperoort, M., Cao, Y., Shi, J., Tabas, I. A., & Tao, W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00629-x · Cited by 533 · see citing works

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499 · see citing works

Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 419 · see citing works

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors

Lechner, K., von Schacky, C., McKenzie, A. L., Worm, N., Nixdorff, U., Lechner, B., Kränkel, N., Halle, M., Krauss, R. M., & Scherr, J. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319869400 · Cited by 371 · see citing works

The integration of inflammaging in age-related diseases

Fülöp, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 356 · see citing works

Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis

Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 249 · see citing works

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223 · see citing works

Oxidation of polyunsaturated fatty acids to produce lipid mediators

Christie, W. W., & Harwood, J. L. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190082 · Cited by 223 · see citing works

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

Karunakaran, D., Nguyen, M.-A., Geoffrion, M., Vreeken, D., Lister, Z., Cheng, H. S., Otte, N., Essebier, P., Wyatt, H., Kandiah, J. W., et al. (2020) · Circulation · doi:10.1161/circulationaha.118.038379 · Cited by 219 · see citing works

LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation

Ye, Z.-M., Yang, S., Xia, Y., Hu, R., Chen, S., Li, B., Chen, S.-L., Luo, X., Mao, L., Li, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1409-4 · Cited by 208 · see citing works

Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation

Bai, R., Yao, C., Zhong, Z., Ge, J., Bai, Z., Ye, X., Xie, T., & Xie, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113165 · Cited by 190 · see citing works

Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment

He, Z., Chen, W., Hu, K., Luo, Y., Zeng, W., He, X., Li, T., Ouyang, J., Li, Y., Xie, L., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01687-1 · Cited by 190 · see citing works

Targeting Mechanosensitive Transcription Factors in Atherosclerosis

Niu, N., Xu, S., Xu, Y., Little, P. J., & Jin, Z. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.02.004 · Cited by 188 · see citing works

The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation

Schilperoort, M., Ngai, D., Sukka, S. R., Avrampou, K., Shi, H., & Tabas, I. A. (2023) · Immunological Reviews · doi:10.1111/imr.13214 · Cited by 181 · see citing works

Mouse Models for Atherosclerosis Research—Which Is My Line?

Oppi, S., Lüscher, T. F., & Stein, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00046 · Cited by 179 · see citing works

Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)

Tian, K., Li, J., & Xu, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.019 · Cited by 178 · see citing works

Inflammation Resolution: Implications for Atherosclerosis

Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 177 · see citing works

Nanoparticle Therapy for Vascular Diseases

Flores, A. M., Ye, J., Jarr, K.-U., Hosseini-Nassab, N., Smith, B. R., & Leeper, N. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311569 · Cited by 152 · see citing works

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Lechner, K., McKenzie, A. L., Kränkel, N., von Schacky, C., Worm, N., Nixdorff, U., Lechner, B., Scherr, J., Weingärtner, O., & Krauss, R. M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0115 · Cited by 141 · see citing works

Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability

Yurdagul, A. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316233 · Cited by 137 · see citing works

Evidence for the Benefits of Melatonin in Cardiovascular Disease

Tobeiha, M., Jafari, A., Fadaei, S., Mirazimi, S. M. A., Dashti, F., Amiri, A., Khan, H. Z., Asemi, Z., Reiter, R. J., Hamblin, M. R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.888319 · Cited by 126 · see citing works

An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.

Hu, Z., Guan, Y., Hu, W., Xu, Z., & Ishfaq, M. (2022) · PubMed Central · doi:10.22038/ijbms.2022.60380.13381 · Cited by 121 · see citing works

Inflammation, infection and atherosclerosis

Shah, P. K. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.004 · Cited by 111 · see citing works

Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation

Bäck, M., & Hansson, G. K. (2019) · The FASEB Journal · doi:10.1096/fj.201802445r · Cited by 107 · see citing works

First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis

Trzeciak, A. J., Wang, Y., & Perry, J. S. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.001 · Cited by 107 · see citing works

N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1

Dong, G., Yu, J., Shan, G., Su, L., Yu, N., & Yang, S.-S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.731810 · Cited by 107 · see citing works

Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis

He, H., Han, Q., Wang, S., Long, M., Zhang, M., Li, Y., Zhang, Y., & Gu, N. (2023) · ACS Nano · doi:10.1021/acsnano.3c01420 · Cited by 107 · see citing works

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy

Dabravolski, S. A., Sukhorukov, V. N., Kalmykov, V. A., Grechko, A. V., Shakhpazyan, N. K., & Orekhov, A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10020254 · Cited by 96 · see citing works

HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis

Liu, T., Xiang, A., Peng, T., Doran, A. C., Tracey, K. J., Barnes, B. J., Tabas, I. A., Son, M., & Diamond, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907490116 · Cited by 93 · see citing works

Inflammation and Cardiovascular Disease: The Future

Arnold, N., Lechner, K., Waldeyer, C., Shapiro, M. D., & Köenig, W. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.50 · Cited by 89 · see citing works

Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies

Porsch, F., Mallat, Z., & Binder, C. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab285 · Cited by 86 · see citing works

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection

Arnardottir, H., Thul, S., Pawelzik, S., Karadimou, G., Artiach, G., Gallina, A. L., Mysdotter, V., Carracedo, M., Tarnawski, L., Caravaca, A. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142883 · Cited by 85 · see citing works

Mechanosensitive Channel PIEZO1 Senses Shear Force to Induce KLF2/4 Expression via CaMKII/MEKK3/ERK5 Axis in Endothelial Cells

Zheng, Q., Zou, Y., Teng, P., Chen, Z., Wu, Y., Dai, X., Li, X., Hu, Z., Wu, S., Xu, Y., et al. (2022) · Cells · doi:10.3390/cells11142191 · Cited by 83 · see citing works

Pro-resolving lipid mediators in vascular disease

Conte, M. S., Desai, T. A., Wu, B., Schaller, M. S., & Werlin, E. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97947 · Cited by 81 · see citing works

Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis

Geng, S., Zhang, Y., Lee, C., & Li, L. (2019) · Science Advances · doi:10.1126/sciadv.aav2309 · Cited by 80 · see citing works

Implications for the role of lipopolysaccharide in the development of atherosclerosis

Gorabi, A. M., Kiaie, N., Khosrojerdi, A., Jamialahmadi, T., Al‐Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.08.015 · Cited by 80 · see citing works

Epigenetics of chronic inflammatory diseases

Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79 · see citing works

Current Development of Nano-Drug Delivery to Target Macrophages

Cai, D., Gao, W., Li, Z., Zhang, Y., Xiao, L., & Xiao, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10051203 · Cited by 73 · see citing works

Do patients benefit from omega-3 fatty acids?

Sherratt, S. C. R., Mason, R. P., Libby, P., Steg, P. G., & Bhatt, D. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad188 · Cited by 71 · see citing works

Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells

Chistiakov, D. A., Kashirskikh, D. A., Khotina, V. A., Grechko, A. V., & Orekhov, A. N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111798 · Cited by 70 · see citing works

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis

Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 62 · see citing works

Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases

Ramprasath, T., Han, Y., Zhang, D., Yu, C., & Zou, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.731701 · Cited by 62 · see citing works

C-type lectin Mincle mediates cell death–triggered inflammation in acute kidney injury

Tanaka, M., Saka-Tanaka, M., Ochi, K., Fujieda, K., Sugiura, Y., Miyamoto, T., Kohda, H., Ito, A., Miyazawa, T., Matsumoto, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192230 · Cited by 62 · see citing works

Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease

Xia, M., Yang, X., & Qian, C. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.10.043 · Cited by 62 · see citing works

Lipoxin Mimetics and the Resolution of Inflammation

Godson, C., Guiry, P. J., & Brennan, E. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-085407 · Cited by 58 · see citing works

Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives

Gouda, N. A., Alshammari, S. O., Abourehab, M. A. S., Alshammari, Q. A., & Elkamhawy, A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01366-y · Cited by 58 · see citing works

An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease

Altamura, S., Pietropaoli, D., Lombardi, F., Pinto, R. D., & Ferri, C. (2023) · Biomedicines · doi:10.3390/biomedicines11113033 · Cited by 58 · see citing works

Inflammation in atherosclerotic cardiovascular disease

Shah, P. K., & Lecis, D. (2019) · F1000Research · doi:10.12688/f1000research.18901.1 · Cited by 58 · see citing works

Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis

Opoku, E., Traughber, C. A., Zhang, D. K. Y., Iacano, A. J., Khan, M. R., Han, J., Smith, J. D., & Gulshan, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715211 · Cited by 53 · see citing works

Millet shell polyphenols prevent atherosclerosis by protecting the gut barrier and remodeling the gut microbiota in ApoE −/− mice

Liu, F., Shan, S., Li, H., Shi, J., Hao, R., Yang, R., & Li, Z. (2021) · Food & Function · doi:10.1039/d1fo00991e · Cited by 53 · see citing works

Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis

Kasikara, C., Schilperoort, M., Gerlach, B. D., Xue, C., Wang, X., Zheng, Z., Kuriakose, G., Dorweiler, B., Zhang, H., Fredman, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145275 · Cited by 51 · see citing works

Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease

Teng, C., Lin, C., Huang, F., Xing, X., Chen, S., Ye, L., Azevedo, H. S., Xu, C., Wu, Z., Chen, Z., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.005 · Cited by 50 · see citing works

Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway

Fan, Y., Liu, J., Miao, J., Zhang, X., Yan, Y., Bai, L., Chang, J., Wang, Y., Wang, L., Bian, Y., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114106 · Cited by 50 · see citing works

Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans

Fan, L., Liu, J., Hu, W., Chen, Z., Lan, J., Zhang, T., Zhang, Y., Wu, X., Zhong, Z., Zhang, D., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00945-0 · Cited by 47 · see citing works

Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis

Oliveira, H. C. F., & Vercesi, A. E. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100840 · Cited by 47 · see citing works

Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation

Ziegon, L., & Schlegel, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010275 · Cited by 45 · see citing works

Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation

Cimmino, G., Muscoli, S., Rosa, S. D., Cesaro, A., Perrone, M. A., Selvaggio, S., Selvaggio, G., Aimo, A., Pedrinelli, R., Mercuro, G., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001450 · Cited by 45 · see citing works

Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment

Yang, B., Hang, S., Xu, S., Gao, Y., Yu, W., Zang, G., Zhang, L., & Wang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32073 · Cited by 45 · see citing works

The gut–immune axis during hypertension and cardiovascular diseases

Dinakis, E., O’Donnell, J. A., & Marques, F. Z. (2024) · Acta Physiologica · doi:10.1111/apha.14193 · Cited by 45 · see citing works

The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis

Hua, Y., Zhang, J., Liu, Q., Su, J., Zhao, Y., Zheng, G., Yang, Z., Zhuo, D., Ma, C., & Fan, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831847 · Cited by 45 · see citing works

Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A

Zhang, L., Lu, L., Zhong, X., Yue, Y., Hong, Y., Li, Y., & Li, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.006 · Cited by 44 · see citing works

Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

Wei, C., Jiang, Z., Li, C., Li, P., & Fu, Q. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214655 · Cited by 43 · see citing works

C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway

Zhang, H., Gong, X., Ni, S., Wang, Y., Zhu, L., & Ji, N. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105934 · Cited by 43 · see citing works

Macrophages: First guards in the prevention of cardiovascular diseases

Nasser, M. I., Zhu, S., Huang, H., Zhao, M., Wang, B., Huang, P. C., Geng, Q., & Zhu, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117559 · Cited by 43 · see citing works

Animal models of human atherosclerosis: current progress

Poznyak, A. V., Silaeva, Y. Y., Orekhov, A. N., & Deykin, A. V. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209557 · Cited by 43 · see citing works

Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease

Schaller, M. S., Chen, M., Colas, R. A., Sorrentino, T. A., Lazar, A., Grenon, S. M., Dalli, J., & Conte, M. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016113 · Cited by 43 · see citing works

Diverse Epigenetic Regulations of Macrophages in Atherosclerosis

Yang, H., Sun, Y., Li, Q., Jin, F., & Dai, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.868788 · Cited by 43 · see citing works

Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy

Guo, L., Miao, Y., Wang, Y., Zhang, Y., Zhou, E.-F., Wang, J., Zhao, Y., Li, L., Wang, A., Gan, Y., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204822 · Cited by 43 · see citing works

Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis

Jin, F., Li, J., Guo, J., Doeppner, T. R., Hermann, D. M., Yao, G., & Dai, Y. (2021) · European Heart Journal Open · doi:10.1093/ehjopen/oeab022 · Cited by 41 · see citing works

Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease

Gonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 41 · see citing works

Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis

Yurdagul, A. (2021) · Immunometabolism · doi:10.20900/immunometab20210017 · Cited by 40 · see citing works

Lipid efflux mechanisms, relation to disease and potential therapeutic aspects

Castaño, D., Rattanasopa, C., Monteiro-Cardoso, V. F., Corlianò, M., Liu, Y., Zhong, A., Rusu, M., Liehn, E. A., & Singaraja, R. R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.013 · Cited by 37 · see citing works

Race-Based and Sex-Based Differences in Bioactive Lipid Mediators after Myocardial Infarction

Halade, G. V., Kain, V., Dillion, C., Beasley, T. M., Dudenbostel, T., Oparil, S., & Limdi, N. A. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12730 · Cited by 37 · see citing works

The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease

Silva, L. F., Vangipurapu, J., & Laakso, M. (2021) · Metabolites · doi:10.3390/metabo11100691 · Cited by 36 · see citing works

Regulatory mechanisms of Sesn2 and its role in multi-organ diseases

Wang, J., Wang, S., Xiao, M., Zhang, J., Wang, J., Guo, Y., Tang, Y., & Gu, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105331 · Cited by 35 · see citing works

Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies

Laera, N., Malerba, P., Vacanti, G., Nardin, S., Pagnesi, M., & Nardin, M. (2023) · Life · doi:10.3390/life13112128 · Cited by 34 · see citing works

A Pro-resolving Role for Galectin-1 in Acute Inflammation

Law, H. L., Wright, R. D., Iqbal, A. J., Norling, L. V., & Cooper, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00274 · Cited by 34 · see citing works

Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells

Schindler, L., Zwissler, L., Krammer, C., Hendgen-Cotta, U. B., Rassaf, T., Hampton, M. B., Dickerhof, N., & Bernhagen, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0420-242rrr · Cited by 34 · see citing works

Sialic acids promote macrophage M1 polarization and atherosclerosis by upregulating ROS and autophagy blockage

Hu, X., Li, Y., Chen, Q., Wang, T., Ma, L., Zhang, W., Yu, R., Zhang, J., Wan, J., Yu, C., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110410 · Cited by 34 · see citing works

Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis

Lobos, C. A., González, L., Bulnes, J. F., Figuls, M. R. I., Venturelli, P. M., & Rodríguez, G. M. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02291-4 · Cited by 33 · see citing works

Epigenetic Mechanisms in Vascular Inflammation: Modulation of Endothelial Adhesion Molecules and Endothelium-Leukocyte Adhesion

Calabriso, N., Massaro, M., Scoditti, E., Carluccio, C., Verri, T., & Carluccio, M. A. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809194 · Cited by 33 · see citing works

Macrophage DNases Limit Neutrophil Extracellular Trap–Mediated Defective Efferocytosis in Atherosclerosis

Dhawan, U. K., Vartak, T., Englert, H., Russo, S., Vasconcellos, L. R. C., Singhal, A., Chakraborty, R., Bhagat, K. K., McDonnell, C. O., Connolly, M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326353 · Cited by 33 · see citing works

Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment

Zhai, T., Wang, P., Hu, X., & Zheng, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3900835 · Cited by 33 · see citing works

Intraperitoneal Oil Application Causes Local Inflammation with Depletion of Resident Peritoneal Macrophages

Alsina‐Sanchís, E., Mülfarth, R. I., Moll, I., Mogler, C., Rodríguez‐Vita, J., & Fischer, A. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0650 · Cited by 32 · see citing works

Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

Huang, C., Huang, W., Zhang, L., Zhang, C., Zhou, C., Wei, W., Li, Y., Zhou, Q., Chen, W., & Tang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051083 · Cited by 32 · see citing works

The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability

Wu, X., Huang, L., Huang, Z.-R., Lu, L., Luo, B., Cai, W., Liu, A.-M., & Wang, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915126 · Cited by 32 · see citing works

Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment

Arnold, N., & Köenig, W. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70020 · Cited by 31 · see citing works

Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis

Shea, S., Navas‐Acién, A., Shimbo, D., Brown, E. R., Budoff, M. J., Bancks, M. P., Barr, R. G., & Kronmal, R. A. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011981 · Cited by 31 · see citing works

Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome

Trovato, E., Rubegni, P., & Prignano, F. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2093106 · Cited by 31 · see citing works

Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis

Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 30 · see citing works

Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis

Pang, A. S.-R., Dinesh, T., Pang, N. Y.-L., Dinesh, V., Pang, K., Yong, C., Lee, S., Yip, G. W., Bay, B., & Srinivasan, D. K. (2024) · Molecules · doi:10.3390/molecules29122873 · Cited by 27 · see citing works

Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics

Liu, Y., Li, C., Yang, X. P., Yang, B. T., & Fu, Q. (2024) · Biomaterials Science · doi:10.1039/d4bm00415a · Cited by 30 · see citing works

Linkage of circadian rhythm disruptions with Alzheimer's disease and therapeutic interventions

Madhamanchi, K., Zhang, J., & Melkani, G. C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.011 · Cited by 30 · see citing works

Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 30 · see citing works

Effects of neutrophil fate on inflammation

Xiao, Y., Yang, C. Z., Liu, W., Liu, K., Wang, Y., Xu, F., Wang, D., & Yang, Y. (2023) · Inflammation Research · doi:10.1007/s00011-023-01811-2 · Cited by 30 · see citing works

Friend or foe? Inflammation and the foreign body response to orthopedic biomaterials

Gibon, E., Takakubo, Y., Zwingenberger, S., Gallo, J., Takagi, M., & Goodman, S. B. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37599 · Cited by 29 · see citing works

Fine-tuning inflammation-resolution programs

Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities

Subramanian, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_361

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411 · see citing works

Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?

Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22 · see citing works